Depressive Symptoms and Engagement in Human Immunodeficiency Virus Care Following Antiretroviral Therapy Initiation
Author(s) -
Angela M. Bengtson,
Brian W. Pence,
Matthew J. Mimiaga,
Bradley N. Gaynes,
Richard D. Moore,
Katerina Christopoulos,
Conall O’Cleirigh,
David J. Grelotti,
Sonia Napravnik,
Heidi M. Crane,
Michael J. Mugavero
Publication year - 2018
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciy496
Subject(s) - medicine , antiretroviral therapy , human immunodeficiency virus (hiv) , sida , viral disease , virology , immunopathology , lentivirus , depression (economics) , immunology , intensive care medicine , viral load , economics , macroeconomics
The effect of depressive symptoms on progression through the human immunodeficiency virus (HIV) treatment cascade is poorly characterized.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom